Risk of ovarian cancer in women with first-degree relatives with cancer

Acta Obstetricia et Gynecologica Scandinavica

Volumn 88, Issue 4, 2009, Pages 449-456

  Soegaard, Marie ^a   Frederiksen, Kirsten ^a   Jensen, Allan ^a   Høgdall, Estrid ^a   Høgdall, Claus ^b   Blaakaer, Jan ^c   Ramus, Susan J ^d   Gayther, Simon A ^d   Kjaer, Susanne K ^a,b,e  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e Rigshospitalet   (Denmark)

Author keywords

family cancer history; hereditary breast and ovarian cancer; hereditary cancer; Ovarian cancer

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; AGE; BREAST TUMOR; COLORECTAL TUMOR; CONFIDENCE INTERVAL; DENMARK; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; MOTHER; ONSET AGE; OVARY TUMOR; PATHOLOGY; PROSTATE TUMOR; RISK; RISK FACTOR; SIBLING;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; DENMARK; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOTHERS; ODDS RATIO; OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS; RISK FACTORS; SIBLINGS;

EID: 64849114271     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340902807207     Document Type: Article

References (30)

1. Amos CI, Struewing JP. Genetic epidemiology of epithelial ovarian cancer. Cancer. 1993;71:566-72.
2. Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol. 1998;105:493-9.
3. Lynch HT, Guirgis HA, Albert S, Brennan M, Lynch J, Kraft C, et al. Familial association of carcinoma of the breast and ovary. Surg Gynecol Obstet. 1974;138:717-24.
4. Kirchhoff T, Satagopan JM, Kauff ND, Huang H, Kolachana P, Palmer C, et al. Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer. J Natl Cancer Inst. 2004;96:68-70.
5. Niell BL, Rennert G, Bonner JD, Almog R, Tomsho LP, Gruber SB. BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. J Natl Cancer Inst. 2004;96:15-21.
6. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997;336:1401-8.
7. Kirchhoff T, Kauff ND, Mitra N, Nafa K, Huang H, Palmer C, et al. BRCA mutations and risk of prostate cancer in Ashkenazi Jews. Clin Cancer Res. 2004;10:2918-21.
8. Giusti RM, Rutter JL, Duray PH, Freedman LS, Konichezky M, Fisher-Fischbein J, et al. A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet. 2003;40:787-92.
9. Ikonen T, Matikainen MP, Syrjakoski K, Mononen N, Koivisto PA, Rokman A, et al. BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland. J Med Genet. 2003;40:e98.
10. Sinclair CS, Berry R, Schaid D, Thibodeau SN, Couch FJ. BRCA1 and BRCA2 have a limited role in familial prostate cancer. Cancer Res. 2000;60:1371-5.
11. Hamel N, Kotar K, Foulkes WD. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer. BMC Med Genet. 2003;4:7.
12. Tung KH, Goodman MT, Wu AH, McDuffie K, Wilkens LR, Nomura AM, et al. Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives. Am J Epidemiol. 2004;159:750-8.
13. Negri E, Pelucchi C, Franceschi S, Montella M, Conti E, Dal ML, et al. Family history of cancer and risk of ovarian cancer. Eur J Cancer. 2003;39:505-10.
14. Auranen A, Pukkala E, Makinen J, Sankila R, Grenman S, Salmi T Cancer incidence in the first-degree relatives of ovarian cancer patients. Br J Cancer. 1996;74:280-4.
15. Lorenzo BJ, Rawal R, Hemminki K. Familial association of specific histologic types of ovarian malignancy with other malignancies. Cancer. 2004;100:1507-14.
16. Kerber RA, Slattery ML. The impact of family history on ovarian cancer risk. The Utah Population Database. Arch Intern Med. 1995;155:905-12.
17. Purdie D, Green A, Bain C, Siskind V, Ward B, Hacker N, et al. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer. 1995;62: 678-84.
18. Soegaard M, Jensen A, Frederiksen K, Høgdall E, Høgdall C, Blaakær J, et al. Accuracy of self-reported family history of cancer in a large case-control study of ovarian cancer. Cancer Causes Control. 2008;19:469-79.
19. Glud E, Kjaer SK, Thomsen BL, Hogdall C, Christensen L, Hogdall E, et al. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med. 2004; 164:2253-9.
20. Osterlind A, Jensen OM. Evaluation of cancer registration in Denmark in 1977. Preliminary evaluation of cancer registration by the Cancer Register and the National Patient Register. Ugeskr Laeger. 1985;147:2483-8.
21. Storm HH. Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol. 1988;17:/44-9.
22. Soegaard M, Jensen A, Hogdall E, Christensen L, Hogdall C, Blaakaer J, et al. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA Study. Cancer Epidemiol Biomarkers Prev. 2007; 16:1160-6.
23. Walker GR, Schlesselman JJ, Ness RB. Family history of cancer, oral contraceptive use, and ovarian cancer risk. Am J Obstet Gynecol. 2002;186:8-14.
24. Schildkraut JM, Thompson WD. Relationship of epithelial ovarian cancer to other malignancies within families. Genet Epidemiol. 1988;5:355-67.
25. Parazzini F, Negri E, La VC, Restelli C, Franceschi S. Family history of reproductive cancers and ovarian cancer risk: an Italian case-control study. Am J Epidemiol. 1992;135:35-40.
26. Boyd J, Rubin SC. Hereditary ovarian cancer: molecular genetics and clinical implications. Gynecol Oncol. 1997;64: 196-206.
27. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet. 2001;68:700-10.
28. Rader JS, Neuman RJ, Brady J, Babb S, Temple S, Kost E, et al. Cancer among first-degree relatives of probands with invasive and borderline ovarian cancer. Obstet Gynecol. 1998;92:589-95.
29. Purdie DM, Siskind V, Bain CJ, Webb PM, Green AC. Reproduction-related risk factors for mucinous and nonmucinous epithelial ovarian cancer. Am J Epidemiol. 2001;153: 860-4.
30. Kurian AW, Balise RR, McGuire V, Whittemore AS. Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol. 2005;96:520-30.